Share This

Public company info - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. - H Shares , 01349.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. - H Shares, 01349.HK - Profit Loss 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12
Turnover 1,031,160 1,140,313 833,803 1,029,295 741,841 497,694 621,870 579,463 470,900 415,925 232,527 133,890 92,390 61,905 31,990
Operating Profit 133,271 217,378 173,031 247,482 93,015 76,001 155,117 153,056 129,960 108,360 63,866 42,489 6,932 -5,050 -21,647
Exceptional Items 0 0 0 0 0 0 0 0 0 0 0 0 -2,946 -2,545 -1,483
Associates 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Taxation 132,294 215,921 176,701 246,312 93,890 70,496 150,838 145,950 128,099 98,946 57,700 37,627 3,986 -7,595 -23,130
Taxation -4,979 3,540 12,442 25,657 2,977 10,337 20,830 18,903 17,605 15,405 5,264 5,255 2,801 879 1,069
Minority Interests -725 -915 -403 -6,704 -21,216 -15,128 -8,700 -676 -7,764 -3,677 -723 1,546 -2,496 -1,154 -797
Net Profit 137,997 213,296 164,663 227,358 112,129 75,287 138,708 127,723 118,258 87,218 53,159 30,826 3,681 -7,320 -23,402
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand
Major Items
Depreciation 80,970 60,853 51,978 36,538 34,219 44,032 38,627 29,014 24,393 15,522 10,470 6,017 5,394 5,142 5,406
Interest Paid 1,538 1,055 5,601 6,299 6,491 5,505 4,279 7,106 1,870 5,440 6,166 4,862 2,946 2,545 1,483
Interest Capitalized 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-current Assets Revaluation / Disposal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxation Rate (%) -3.76 1.64 7.04 10.42 3.17 14.66 13.81 12.95 13.74 15.57 9.12 13.97 70.27
Turnover Growth (%) -9.57 36.76 -18.99 38.75 49.06 -19.97 7.32 23.05 13.22 78.87 73.67 44.92 49.24 93.51 28.33
Net Profit Growth (%) -35.3 29.53 -27.58 102.76 48.94 -45.72 8.6 8.0 35.59 64.07 72.45 737.44
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.